BIOFILM AND OUR CLINICAL EXPERIENCE by TANJA PLANINŠEK RUČIGAJ
57
Clinical ObservationActa Med Croatica, 70 (2016) 57-59
INTRODUCTION
Bioi lm is a community of microorganisms surround-
ed by an extracellular polymeric, polysaccharide ma-
trix at the surface (1). Bioi lms were discovered in the 
1650s by van Leeuwenhoek, but it was only in 1978 
that Costerton wrote about the ‘Bacteria Stick’. In 
1978, research on bioi lm bacteria has exploded (2). 
Bioi lms play a signii cant role in a large number of 
infections, in particular in chronic wounds (1). Some 
of the frequent microorganism that make a bioi lm 
on the wounds are Staphylococcus (S.) epidermidis, S. 
aureus and Pseudomonas (P.) aeruginosa (3,4). It was a 
big problem to prove the bioi lm formation in wounds. 
Now we can identify bioi lm formation by light mi-
croscopy, electron microscopy and confocal laser scan-
ning microscopy (5). We can demonstrate extracellu-
lar polymeric, polysaccharide matrix surrounding the 
bacteria in bioi lm by staining with ruthenium red, car-
bohydrate stains and concanavalin A (6). James et al. 
evaluated 16 acute and 50 chronic wounds. h ey found 
bioi lms in 6% of acute and 60% of chronic wounds (7).
Antiseptics are preferred to antibiotics for removal 
of bioi lms. Silver and polyhexamethylene biguanide 
(PHMB) are very ef ective against planktonic bacteria 
and immature bioi lms. When applied on mature bio-
i lms, they can only inhibit further growth and prevent 
bacteria from spreading beyond the bioi lm but not 
resolve the infection (8,9). h e antimicrobial ei  cacy 
of silver dressings against bacterial bioi lms was inves-
tigated on in vitro and in vivo models. Hegger et al. 
showed that dressings with silver reduced bioi lm less 
than 90% in one-week treatment in an animal model 
(10). However, in vitro studies produced better results. 
Percival et al. report that hydroi ber dressings with 
silver acting against bacterial bioi lms proved ei  cient 
at er 24-h treatment and killed total bacterial bioi lm 
within 48 h (11). 
OUR CLINICAL EXPERIENCE
Study 1. In this case study we evaluated the ef ects of 
two alginate dressings on healing during the treatment 
of 20 venous leg ulcers. Results: Ulcers treated with al-
ginate with silver (Silvercel®) were smaller by 15.4% 
and ulcers treated with calcium-alginate without silver 
were larger by 0.7% (12,13) . 
Study 2. In a large-scale, comparative, randomized 
study we compared the ef ects on healing of foam dress-
ing with silver (Contreet-H®) versus ‘local-best-prac-
tice’ in the treatment of 619 ulcers with delayed heal-
ing. Results: Wound-area decreased faster in patients 
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treated with foam dressing with silver (50% vs. 34.3% 
reduction). h e foam dressing with silver signii cantly 
promoted positive wound progress in 67% compared 
to 51% using ‘local-best-practice’ (12,14). 
Study 3. In a comparative clinical trial we compared 
hydroi ber dressing and ointments in changing micro-
bial colonization and healing of 24 venous ulcers in 7 
weeks. Results: h e most frequently isolated bacteri-
um in the group with hydroi ber dressing (Aquacel®) 
was P. aeruginosa (in the beginning: 44.4%; at the end: 
20%), as well as in the group with ointment (in the 
beginning: 53.3%; at the end: 60%). h e mean wound 
size in patients treated with hydroi ber dressing was 
9.6 cm² at the beginning and 8.8 cm² at the end. h e 
mean wound size in patients treated with ointment 
was 16.4 cm² at the beginning and 19.5 cm² at the end 
(12,15). 
Study 4. h is small study included i ve patients with 
no progress in venous leg ulcer healing over a mean of 
5.2 years. At the beginning, their wound beds were in 
stage C3 and mean size 24.44 cm². Foam AMD with 
PHMB® were changed every 3-4 days. Treatment last-
ed for a mean of 44.7 days or until the wound healed. 
Results: One wound healed, while the rest were small-
er, mean 17.69 cm² at the end. Wound beds were in 
stage A2 in all patients (12,16). 
Study 5. In a randomized clinical study, we evaluated 
the ef ects on healing and pain in 14 venous leg ulcers 
with wound beds C2-3 treated with honey (Vivamel®, 
group 1) and 16 venous leg ulcers with wound bed C3 
treated with antiseptic (AMD with PHMB®, group 2). 
Results: In group 1, healing results were achieved fast-
er (at er one week), but in group 2 there was no pain 
which persisted in group 1. At er two weeks, all ulcers 
from both groups were in B2 stage according to Falan-
ga’s classii cation of wound bed (12,17).
All the above studies measured only wound size and 
isolated bacteria, but did not search for bioi lm be-
cause at that time we did not have possibilities to do 
it. All the wounds had been persisting for a long time 
and their wound bed was slough, so the presence of 
bioi lm was quite likely.
CONCLUSION
In our study, we demonstrated that wounds with cri-
tical colonization and probably bioi lms healed faster 
when we used dressings with antiseptics.
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Bakterije koje su organizirane u bioﬁ lmu nisu osjetljive na uobičajeno liječenje oblogama ili antibioticima. Najuspješnije 
uklanjamo njihove kolonije kirurškim debridmanom, ali nemamo takve mogućnosti na svakom mjestu. Obloge sa srebrom 
i drugim antisepticima često su jedino raspoloživo sredstvo medicinskim sestrama u bolesnikovu domu ili dermatologu u 
ambulanti. U našim kliničkim studijama prije nekoliko godina pokazali smo da su obloge s antisepticima bile učinkovite u 
svakodnevnoj kliničkoj praksi za uklanjanje bakterija/bioﬁ lmova iz kroničnih rana.
Ključne riječi: rana, bioﬁ lm, infekcija, antimikrobna obloga, anti-bioﬁ lm
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